Combined cancer immunotherapy with lipid nanoparticle delivery of oligo-based cGAS-agonistic adjuvant and peptide or mRNA vaccines
Shurong Zhou(University of Michigan), Guizhi Zhu(University of Michigan), Yu Hao(University of Michigan), Ting Su(Sun Yat-sen University), Furong Cheng(Cangzhou Central Hospital), You Xu(University of Michigan), Qiyan Wang(Guiyang Medical University), Yuqing Liang(University of Michigan)
Cited by 9
Related Papers
Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines
|Journal of Controlled Release|2022|344
Hyaluronic Acid-Decorated Graphene Oxide Nanohybrids as Nanocarriers for Targeted and pH-Responsive Anticancer Drug Delivery
|ACS Applied Materials & Interfaces|2014|202
Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
|Advanced Science|2022|73
Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases
|Accounts of Chemical Research|2023|71
Small GTPases: Structure, biological function and its interaction with nanoparticles
|Asian Journal of Pharmaceutical Sciences|2018|70